Technology
Health
Pharmaceutical

Revance Therapeutics

$11.61
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.32 (-2.68%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell RVNC and other stocks, options, ETFs, and crypto commission-free!

About

Revance Therapeutics, Inc. Common Stock, also called Revance Therapeutics, is a clinical stage biotechnology company. Read More It is engaged in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic, and therapeutic applications. The firm focuses on production of daxibotulinumtoxinA, a botulinum toxin, for a broad spectrum of aesthetic and therapeutic indications, including facial wrinkles and muscle movement disorders. The company was founded by Jacob M. Waugh and L. Daniel Browne on August 10, 1999 and is headquartered in Newark, CA.

Employees
170
Headquarters
Newark, California
Founded
1999
Market Cap
510.89M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
343.33K
High Today
$12.14
Low Today
$11.54
Open Price
$11.99
Volume
93.95K
52 Week High
$32.45
52 Week Low
$10.51

Collections

Technology
Health
Pharmaceutical
Therapy
Medical
Biotechnology
Manufacturing
2014 IPO

News

Yahoo FinanceMay 7

Is Revance Therapeutics Inc (RVNC) A Good Stock To Buy?

While the market driven by short-term sentiment influenced by uncertainty regarding the future of the interest rate environment in the US, declining oil prices and the trade war with China, many smart money investors kept their optimism regarding the current bull run in the fourth quarter, while still hedging many of their long positions.

309
Yahoo FinanceMay 1

A Spotlight On Revance Therapeutics, Inc.'s (NASDAQ:RVNC) Fundamentals

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Building up an investment case requires looking at a stock holistically. Today I've chosen to put the spotlight on Revance Therapeutics, Inc. (NASDAQ:RVNC) due to its excellent fundamentals in more than one area. RVNC is a company with strong financial health as well as an optimistic future outlook. Below, I've touched on some key aspects you should know on a high level. For those int...

131
Yahoo FinanceMay 1

Will Revance Therapeutics (RVNC) Report Negative Earnings Next Week? What You Should Know

Wall Street expects a year-over-year increase in earnings on higher revenues when Revance Therapeutics (RVNC) reports results for the quarter ended March 2019. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.

65

Earnings

-$1.12
-$0.98
-$0.85
-$0.71
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 1, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.